Nidra

Restless Legs Syndrome (RLS)

CommercialActive

Key Facts

Indication
Restless Legs Syndrome (RLS)
Phase
Commercial
Status
Active
Company

About Noctrix Health

Noctrix Health is a private, commercial-stage medical device company based in San Jose, California, founded in 2018. The company has successfully developed and launched Nidra, an FDA-authorized wearable neuromodulation device for treating Restless Legs Syndrome (RLS), supported by pivotal clinical trial data published in a peer-reviewed journal. With recent CMS reimbursement codes, a $33.5M financing round, and inclusion in AASM clinical guidelines, Noctrix is positioned for U.S. commercialization growth while potentially expanding its technology platform to other chronic neurological disorders.

View full company profile